We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
26
Lam Research
LRCX
$382B
$122M 0.74%
1,145,150
-35,180
-3% -$3.37M
QCOM icon
27
Qualcomm
QCOM
$176B
$121M 0.74%
609,642
+282,825
+87% +$53.4M
CDNS icon
28
Cadence Design Systems
CDNS
$90B
$115M 0.69%
372,425
+22,227
+6% +$6.58M
ISRG icon
29
Intuitive Surgical
ISRG
$121B
$110M 0.67%
246,867
-10,200
-4% -$4.06M
AMD icon
30
Advanced Micro Devices
AMD
$851B
$106M 0.64%
655,358
-154,041
-19% -$24.8M
PANW icon
31
Palo Alto Networks
PANW
$264B
$105M 0.64%
619,850
+35,808
+6% +$5.36M
EMR icon
32
Emerson Electric
EMR
$82.9B
$105M 0.64%
953,710
-23,867
-2% -$2.64M
DHR icon
33
Danaher
DHR
$135B
$102M 0.62%
409,474
-104,048
-20% -$26.3M
JPM icon
34
JPMorgan Chase
JPM
$939B
$100M 0.61%
496,823
+10,613
+2% +$2.07M
HOLX
35
DELISTED
Hologic
HOLX
$99.8M 0.6%
1,343,586
-28,331
-2% -$2.12M
ECL icon
36
Ecolab
ECL
$75.6B
$87.1M 0.53%
365,852
+2,164
+0.6% +$500K
NU icon
37
Nu Holdings
NU
$68.1B
$86M 0.52%
6,669,000
+4,166,762
+167% +$48.5M
CSCO icon
38
Cisco
CSCO
$450B
$85.7M 0.52%
1,804,236
+273,929
+18% +$13M
ALNY icon
39
Alnylam Pharmaceuticals
ALNY
$36.3B
$85.3M 0.52%
351,228
+34,330
+11% +$5.42M
META icon
40
Meta Platforms (Facebook)
META
$1.51T
$85.2M 0.52%
169,059
+13,360
+9% +$6.49M
AXP icon
41
American Express
AXP
$223B
$83.1M 0.5%
358,913
+15,296
+4% +$3.54M
MELI icon
42
Mercado Libre
MELI
$91.3B
$83M 0.5%
50,531
-2,499
-5% -$3.95M
IQV icon
43
IQVIA
IQV
$34.7B
$82.3M 0.5%
389,152
+102,031
+36% +$23.2M
TSLA icon
44
Tesla
TSLA
$1.24T
$82.1M 0.5%
415,081
-17,262
-4% -$3.02M
ON icon
45
ON Semiconductor
ON
$33.8B
$82M 0.5%
1,196,630
+291,214
+32% +$20.4M
CRWD icon
46
CrowdStrike
CRWD
$187B
$81.6M 0.49%
851,512
-10,072
-1% -$837K
BKNG icon
47
Booking.com
BKNG
$138B
$80.7M 0.49%
509,175
+260,150
+104% +$38.5M
INCY icon
48
Incyte
INCY
$23.5B
$80M 0.48%
1,319,681
-154,116
-10% -$8.73M
PTC icon
49
PTC
PTC
$13.7B
$79.7M 0.48%
438,627
+25,034
+6% +$4.48M
ELV icon
50
Elevance Health
ELV
$81.9B
$77M 0.47%
116,200
+36,845
+46% +$19.5M

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.